Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Med Rep ; 9(2): 407-12, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24337628

RESUMEN

Perturbations in the levels of serotonin expression have a significant impact on behavior and have been implicated in the pathogenesis of several neuropsychiatric disorders including anxiety, mood and appetite. Fetal programming is a risk factor for the development of metabolic diseases during adulthood. Moreover, previous studies have shown that serotonin (5­HT), dopamine and leptin are important in energy balance. In the present study, the impact of maternal malnutrition­induced prenatal undernutrition (UN) was investigated in mice and the expression of 5­HT1A, dopamine (D)1, D2 and Ob­Rb receptors was analyzed in the hypothalamus during adulthood. The UN group showed a low birth weight compared with the control group. With regard to receptor expression, 5­HT1A in the UN group was increased in the hypothalamus and D1 was reduced, whereas D2 showed an increase from postnatal day (P)14 in the arcuate nucleus. Ob­Rb receptor expression was increased in the hypothalamus at P14 and P90. These observations indicated that maternal caloric restriction programs a postnatal body weight gain in offspring with an increased food intake in early postnatal life which continues into adulthood. In addition, UN in mice was found to be affected by Ob­Rb, 5­HT1A and D1/2 receptor expression, indicating that these observations may be associated with hyperphagia and obesity.


Asunto(s)
Metabolismo Energético , Desarrollo Fetal , Receptores Dopaminérgicos/biosíntesis , Receptores de Leptina/biosíntesis , Receptores de Serotonina/biosíntesis , Animales , Peso al Nacer , Restricción Calórica , Dopamina/metabolismo , Ingestión de Alimentos , Femenino , Trastornos Nutricionales en el Feto , Humanos , Hipotálamo/metabolismo , Leptina/metabolismo , Ratones , Embarazo , Factores de Riesgo , Serotonina/metabolismo
2.
J Ethnopharmacol ; 143(2): 716-9, 2012 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-22884870

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Chiranthodendron pentadactylon Larreat is frequently used in Mexican traditional medicine as well as in Guatemalan for several medicinal purposes, including their use in the control of diarrhea. AIM OF THE STUDY: This work was undertaken to obtain additional information that support the traditional use of Chiranthodendron pentadactylon Larreat, on pharmacological basis using the major antisecretory isolated compound from computational, in vitro and in vivo experiments. MATERIALS AND METHODS: (-)-Epicatechin was isolated from ethyl acetate fraction of the plant crude extract. In vivo toxin (Vibrio cholera or Escherichia coli)-induced intestinal secretion in rat jejunal loops models and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis on Vibrio cholera toxin were used in experimental studies while the molecular docking technique was used to conduct computational study. RESULTS: The antisecretory activity of epicatechin was tested against Vibrio cholera and Escherichia coli toxins at oral dose 10 mg/kg in the rat model. It exhibited the most potent activity on Vibrio cholera toxin (56.9% of inhibition). In the case of Escherichia coli toxin its effect was moderate (24.1% of inhibition). SDS-PAGE analysis revealed that both (-)-epicatechin and Chiranthodendron pentadactylon extract interacted with the Vibrio cholera toxin at concentration from 80 µg/mL and 300 µg/mL, respectively. Computational molecular docking showed that epicatechin interacted with four amino acid residues (Asn 103, Phe 31, Phe 223 and The 78) in the catalytic site of Vibrio cholera toxin, revealing its potential binding mode at molecular level. CONCLUSION: The results derived from computational, in vitro and in vivo experiments on Vibrio cholera and Escherichia coli toxins confirm the potential of epicatechin as a new antisecretory compound and give additional scientific support to anecdotal use of Chiranthodendron pentadactylon Larreat in Mexican traditional medicine to treat gastrointestinal disorders such as diarrhea.


Asunto(s)
Antidiarreicos/farmacología , Catequina/farmacología , Diarrea/tratamiento farmacológico , Malvaceae , Extractos Vegetales/farmacología , Animales , Antidiarreicos/química , Catequina/química , Catequina/aislamiento & purificación , Enterotoxinas/administración & dosificación , Flores , Yeyuno/metabolismo , Masculino , Medicina Tradicional , Metanol/química , México , Simulación del Acoplamiento Molecular , Extractos Vegetales/química , Ratas , Ratas Sprague-Dawley , Solventes/química
3.
Vaccine ; 26(52): 6936-44, 2008 Dec 09.
Artículo en Inglés | MEDLINE | ID: mdl-18940223

RESUMEN

We tested two post-exposure prophylaxes (PEPs) for rabies in laboratory animals; one was a traditional antirabies vaccine for humans via intramuscular route (IM), and the other was a DNA vaccine administered by intranasal route (IN). In contrast to The World Health Organization's recommended five-dose PEP, we gave only four doses without hyper-immune antirabies sera, making the PEP more rigorous. All animals were challenged with challenge virus strain (CVS); 16h later, PEP was applied. All animals that received the PEP with DNA/IN survived, and 87% of the rabbits and 80% of the mice that received the PEP with traditional antirabies vaccine/IM survived. Negative controls succumbed to infection. The expression of G protein was detected in the NALT, cerebellum, cerebral cortex (neocortex), cerebellum and hippocampus, mainly in the glial cells (microglia) and microvessels. On the other hand, plasmid construct was detected in brain and its mRNA expression in medium and posterior encephalon. The efficiency of this DNA/IN PEP is probably due to the early expression of the antigen in the brain stimulating the immune system locally.


Asunto(s)
Vacunas Antirrábicas/uso terapéutico , Rabia/prevención & control , Administración Intranasal , Animales , Encéfalo/inmunología , Encéfalo/patología , Encéfalo/virología , Línea Celular , Colorantes , Cricetinae , ADN Complementario/biosíntesis , ADN Complementario/genética , Eosina Amarillenta-(YS) , Femenino , Proteínas de Unión al GTP/genética , Proteínas de Unión al GTP/inmunología , Hematoxilina , Esquemas de Inmunización , Técnicas para Inmunoenzimas , Ratones , Ratones Endogámicos BALB C , Pruebas de Neutralización , Plásmidos/genética , ARN Viral/genética , ARN Viral/inmunología , Conejos , Vacunas Antirrábicas/administración & dosificación , Vacunas Antirrábicas/inmunología , Virus de la Rabia/genética , Virus de la Rabia/inmunología , Vacunas de ADN/administración & dosificación , Vacunas de ADN/inmunología , Vacunas de ADN/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA